Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

Pfizer's 'weak' Q1 numbers bolster case for AZ buy–and post-merger split, too

05.05.2014 / Fierce Pharma

Pfizer has pulled back the veil on its three new operating segments. It's the long-awaited peek at these units, created last July as a prelude to potential sales or spin-offs. Do the numbers bear out analyst enthusiasm for more Pfizer split-up action?

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: